Overview
Xinhua Biotech develops AI-driven macromolecular drugs, focusing on areas with major unmet medical needs such as cancer immunotherapy. It is building an AI-driven intelligent macromolecular drug development platform to improve research and development quality and efficiency.
Connected profiles
Explore
More Health management products
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
信华生物是一家AI驱动大分子药物研发商，公司聚焦于AI在肿瘤免疫治疗等面临巨大的未满足医疗需求的领域，致力于打造AI驱动智能大分子药物开发平台，提升大分子药物研发的质量与效率。